Produktbild
Chilukuri (Hrsg.) Dakshina Murthy

Pharmaceutical Product Development

In Vitro-In Vivo Correlation

Ebook (PDF Format)

During the last two decades, the pharmaceutical industry has been under pressure to reduce development costs and the time needed to bring drugs to market in order to maximize return on investment and bring treatments to patients sooner. To meet these ends, pharmaceutical scientists working in the differing areas of pharmacy, pharmaceutics, and pharmacokinetics are collaborating to address physicochemical and biological issues in the early stages of development to avoid problems in later stages. In Vitro-In Vivo Correlation (IVIVC) is a multidisciplinary tool that has been successfully applied in testing the effectiveness of a drug substance.… Mehr

CHF 70.30

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen
Versandkostenfrei

Produktdetails


Weitere Autoren: Sunkara, Gangadhar (Hrsg.) / Young, David (Hrsg.)
  • ISBN: 978-1-4200-2017-5
  • EAN: 9781420020175
  • Produktnummer: 18417991
  • Verlag: Taylor & Francis Ltd.
  • Sprache: Englisch
  • Erscheinungsjahr: 2007
  • Seitenangabe: 224 S.
  • Plattform: PDF
  • Masse: 7'579 KB

Über den Autor


DAKSHINA MURTHY CHILUKURI is a Senior Reviewer in the Office of Clinical Pharmacology, U.S. Food and Drug Administration (FDA), Silver Spring, Maryland. He is responsible for review of clinical pharmacology-related information in Investigational New Drug Applications (IND) and New Drug Applications (NDA). Previously he has held positions in industry in the areas of design, analysis, and interpretation of pharmacokinetic studies, developing in vitro-in vivo correlation from various dosage forms, and serving as a consultant for pharmaceutical and biotechnology companies working in formulation development, preclinical development, and IND filing. Dr. Chilukuri received the B.Pharm. degree from Kakatiya University, Warangal, India and the Ph.D. degree in pharmaceutical sciences from Medical University of South Carolina, Charleston. GANGADHAR SUNKARA is Associate Director, Pharmacokinetics, Exploratory Development, Novartis Pharmaceuticals, East Hanover, New Jersey. Dr. Sunkara is the author of numerous peer-reviewed scientific publications, presenter at over 20 international scientific meetings, and recipient of the AAPS Graduate Symposium Award in Drug Delivery and Pharmaceutical Technology (2001). He received the B. Pharm. degree and the M. Pharm. degree in pharmaceutics from Kakatiya University, Warangal, India, the Ph.D. degree from the University of Nebraska Medical Center, Omaha, and the M.B.A. degree in finance from Fairleigh-Dickinson University, Madison, New Jersey. DAVID YOUNG is President, U.S. Operations, AGI Therapeutics, Inc., Columbia, Maryland. Before joining AGI, Dr. Young founded GloboMax, and became Executive Vice President of the GloboMax Division of ICON plc, Hanover, Maryland, after his company was acquired by ICON plc. Prior to forming GloboMax, he had a distinguished career in academia, serving as Associate Professor in the Department of Pharmaceutical Sciences and the Managing Director of the Clinical Research Unit at the University of Maryland, Baltimore. Dr. Young received the B.A. degree in physiology from the University of California, Berkeley, the M.S. degree in medical physics from the University of Wisconsin, Madison, and the Pharm.D. degree and the Ph.D. degree in pharmaceutical sciences from the University of Southern California, Los Angeles.

2 weitere Werke von Chilukuri (Hrsg.) Dakshina Murthy:


Bewertungen


0 von 0 Bewertungen

Geben Sie eine Bewertung ab!

Teilen Sie Ihre Erfahrungen mit dem Produkt mit anderen Kunden.